Recursion Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.27 | -100% | -12.34 | -100% |
| P/S |
|
50.31 | 33.44 | 50.48% |
|
|
| P/BV |
|
4.84 | 4.64 | 4.22% |
|
|
| P/FCF |
|
-6.06 | 42.53 | -114.25% |
|
|
| Ev/Ebitda |
|
-5.98 | -17.68 | -66.18% |
|
|
| Ev/S |
|
42.59 | 22.59 | 88.51% |
|
|
| Ev/FCF |
|
-6.32 | 47.55 | -113.3% |
|
|
| E/P |
|
-0.1803 | 0.0182 | -1090.66% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-712.5 | -14.2 | 4916.25% | -805.03 | -11.49% |
| ROE |
|
-70.79 | 9.78 | -823.62% |
|
|
| ROA |
|
-50.19 | 0.33 | -15305.66% |
|
|
| ROIC |
|
-127.47 | 7.63 | -1769.69% |
|
|
| ROS |
|
-735.99 | -26.41 | 2686.38% |
|
|
| ROCE |
|
-75.54 | 14.55 | -619.21% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0229 | -3.87 | -99.41% | -0.0867 | -73.63% |
| Nеt Debt/Ebitda |
|
1.08 | -4.24 | -125.55% |
|
|
| Debt/Ratio |
|
0.0111 | 0.1853 | -94.01% |
|
|
| Debt/Equity |
|
0.0127 | 1.61 | -99.21% |
|
|
| Debt/Net Income |
|
-0.0221 | 10.06 | -100.22% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2368 | -100% |
|
|
| Average dividend growth |
|
0 | 1.48 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4863 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
2128.75 | 30.62 | 6852.16% | ||
| Growth impulse Ebitda in 5 years |
|
419.17 | -17.42 | -2506.26% | ||
| Growth impulse Net Income in 5 years |
|
429.14 | -52.26 | -921.16% | ||
| Growth impulse FCF in 5 years |
|
392.35 | -31.68 | -1338.48% | ||
| Growth impulse EPS in 5 years |
|
186.97 | -61.82 | -402.44% |
IP Score
4.57/10
